6/29/07 Update
At the halfway mark, despite lots of churning, the Nasdaq Biotech Index wound up pretty much where it began the year, closing Friday up .54% YTD (vs. up .24% YTD a week ago). Unfortunately, the smaller-cap stocks in the Charity Contest portfolios can't even claim a break even performance for the first half of the year. At Friday's close, the median for the Contest portfolios was down -4.39%% YTD (vs. down -5.30% YTD a week ago). At the mid-year closing bell, 12 of the 31 Contest portfolios were in the black YTD and the same 12 of 31 beat the NBI.
RCMAC's 26.9% YTD gain keeps him in the lead, with FRED's 26.1% YTD gain a very close No. 2.
Patriotic biofreaks may want to begin celebrating Independence Day this weekend. That's what I'll be doing!
Below is the Top Ten list on 6/29/07:
6/29/07
Rank Name Total
1 RCMAC 26,883
2 FRED 26,107
3 ICEBERG 18,806
4 TECHNET 15,549
5 WILDER 14,755
6 BIOFISH 13,180
7 MOPGCW 10,583
8 MANNY 9,097
9 FILOF 7,845
10 ROBERT 7,027
Portfolio change: AVNC symbol changed to MBRK.
(All corrections greatly appreciated.) |
